Add like
Add dislike
Add to saved papers

Robustness of the Reichert Unistat Bilirubinometer for analysis of hemolyzed samples from neonates.

BACKGROUND AND OBJECTIVES: Bilirubin is routinely measured in neonates to avoid the irreversible effects of kernicterus. Grossly hemolyzed samples are routinely rejected under the assumption that bilirubin cannot be accurately measured in hemolyzed samples. The objective of this study was to determine the effect of hemolysis on bilirubin measurement in neonates.

METHODS: Data included 2-years of paired bilirubin results (n=70) where hemolyzed and non-hemolyzed samples were collected and measured within 6h of each other. Bilirubin results were compared by Passing-Bablock linear regression and difference plots. Bilirubin results were also compared using the Bhutani nomogram to determine if hemolysis affected the hyperbilirubinemia risk-category.

RESULTS: Gross hemolysis resulted in a mean negative bias of -5.2μmol/L (95% CI: -30.7 to 20.3μmol/L). Based on the Bhutani nomogram, 1/70 samples would have been classified as Low-intermediate instead of High-intermediate risk and 3/70 would have been classified as Low instead of Low-intermediate risk; 5/70 samples would have been classified as Low-intermediate instead of Low risk.

CONCLUSIONS: Collectively the data support that neonatal bilirubin may be reported from grossly hemolyzed samples measured using the Reichert Unistat Bilirubinometer. This practice has been adopted at our institution where results are reported with comments describing the effects of hemolysis. Implementation of this approach has decreased the number of blood re-collections in neonates.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app